Inogen Expands Its Respiratory Product Portfolio with Acquisition of Physio-Assist


Latest Financial Results

Q3 2023

Quarter Ended Sep 30, 2023

$84.0M Total third quarter revenue of $84.0 represented a sequential improvement from Q2 revenue of $83.6 million
(10.4%) Total operating expense, excluding one-time costs, declined 10.4% year-over-year
8.7% Rental revenue grew 8.7% year-over-year

For complete information regarding our financials, see our periodic filings

View the Latest Financials

Balance Sheet

Includes Current Assets, Liabilities and Stockholder's Equity

View Balance Sheet

Income Statement

Includes Total Net Sales, Cost & Expenses and Earnings per share

View Income Statement

Cash Flow

Includes Net Income, Adjustments, and Cash flows from investing & financing activities

View Cash Flow